Current management of hereditary cancer syndromes in ovarian and endometrial cancer: a Japanese study
The barriers to uptake of genetic testing arise primarily from inadequate provider communication and patient disinterest in hereditary cancer syndromes.
Authors
- Takashi Ushiwaka (ORCID: https://orcid.org/0000-0003-4096-9521)
- Yasuko Yamamoto
- Kazuhiro Takehara (ORCID: https://orcid.org/0000-0001-8808-3338)
- Tomoka Usami (ORCID: https://orcid.org/0009-0004-5742-6421)
- Natsumi Yamashita (ORCID: https://orcid.org/0000-0001-5133-1879)
- Hiroaki Inui (ORCID: https://orcid.org/0009-0001-7840-1432)
- Mika Okazawa‐Sakai (ORCID: https://orcid.org/0000-0002-6439-856X)
- Takanori Yokoyama (ORCID: https://orcid.org/0009-0000-4055-2166)
- Masao Matsumoto
- Tamaki Tanaka
- Masato Nishimura
Institutions
- Kagawa University (JP)
- Kochi Medical School Hospital (JP)
- Tokushima Prefectural Central Hospital (JP)
- Shikoku Cancer Center (JP)
- Ehime University (JP)
- Kōchi University (JP)
- Tokushima University (JP)
Publication Details
- Journal
- Japanese Journal of Clinical Oncology
- Published
- 2025-11-11
- DOI
- https://doi.org/10.1093/jjco/hyaf176
- Primary Topic
- BRCA gene mutations in cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00